Clinical studies are needed to investigate the endocrine profiles, including measurements of TT, DHT, SHBG, FT and oestradiol, together with LH and FSH, in both men and women with T2DM before and after RGZ and PGZ treatment in double blind, placebo controlled groups. This evidence concerns the gene PLOD1 and type 2 diabetes mellitus.